Organoid Research

Our MEA technology is on the forefront of organoid research.

Neuroscience research is about to change – and Multi Channel Systems is already adapting our MEA solutions to meet your lab’s needs for 3D multielectrode array systems.

Commercial availability of 3D MEA systems

Organoids are now FDA-approved for drug screening, clearing the way for new MEA technologies, as well as cost savings and a reduction in animal usage for researchers. But current multielectrode array solutions fall short: though it’s possible to record data from an organoid with a traditional 2D MEA chip, collapsing and flattening of the organoid structure is inevitable, which could compromise data. Other solutions, such as needle MEAs, harm the organoid. At Harvard Bioscience, a 3D MEA solution is close on the horizon, and we’re preparing to be the first MEA company to launch a commercially available 3D mesh MEA chip that allows for recording of data from inside the organoid without damage to the interior or external structure.